Key Points NeuroOne completed three robotic-assisted large-animal StereoCED procedures. Two procedures combined targeted drug delivery with intracranial electrophysiological recording from the same brain region. The…
August 27, 2026
August 27, 2026
Biomerica Secures $2.23 Million and Launches Strategic Review to Unlock Shareholder Value
Key Points Biomerica agreed to sell 1,393,705 unregistered common shares at $1.60 per share, generating approximately $2.23 million in gross proceeds. The financing includes no…
Key Points Verrica completed enrollment in COVE-2, its first pivotal Phase 3 trial of YCANTH for common warts. A blinded, per-protocol statistical power analysis found…
Key Points The Medifast Metabolic Health Institute focuses on research and credible, evidence-based metabolic-health education. The initiative draws on Medifast’s more than 45 years of…
August 26, 2026
FDA Approves Revolution Medicines’ Rasonque for Metastatic Pancreatic Cancer, Months Ahead of Schedule
Key Points The FDA approved daraxonrasib under the brand name Rasonque for adults with metastatic pancreatic adenocarcinoma who have received at least one prior systemic…
August 25, 2026
OrthoPediatrics Expands Pediatric Hip Surgery Options With Nationwide 3P System Launch
Key Points OrthoPediatrics announced the full U.S. commercial launch of the 3P Pediatric Plating Platform Hip System on August 25, 2026. The nationwide launch follows…
Key Points New sleep apnea patient referrals at Vivos’ Nevada centers increased 212% over the latest six-week period compared with the prior six weeks. Average…
August 20, 2026
Jupiter Neurosciences’ JOTROL Parkinson’s Program: What the Phase 2 Trial Could Mean for JUNS Stock
Key Points Jupiter Neurosciences is enrolling patients in the Phase 2a RESET study of JOTROL for Parkinson’s disease. The randomized, placebo-controlled trial is expected to…
Key Points The V007 study enrolled 242 U.S. patients with end-stage kidney disease who needed new vascular access for hemodialysis. At six months, 81.3% of…
Key Points AvMEDICAL will market CyPath Lung through its national sales team and established federal procurement network. The agreement targets VA medical centers and other…
Key Points CareCloud will develop LailaCare, a customized AI-powered platform for KabaFusion’s home infusion and specialty pharmacy operations. The platform is intended to combine referral intake,…
Key Points AL001 data will be presented during a 10-minute oral session on September 29, 2026, at the ISMRM X-Nuclei MR Workshop. The completed Phase…